
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 218 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: A case control and cohort study”, Semin Arthritis Rheum, vol. 50, pp. 663-672, 2020.
, “Mortality among patients with polymyalgia rheumatica: A retrospective cohort study”, Arthritis Care Res (Hoboken), 2020.
, “Rheumatological conditions as risk factors for self-harm: A retrospective cohort study”, Arthritis Care Res (Hoboken), 2020.
, “Antibiotic use and the risk of rheumatoid arthritis: a population-based case-control study”, BMC Med, vol. 17, p. 154, 2019.
, “Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy”, Cmaj, vol. 191, pp. E597-e603, 2019.
, “Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study”, Ann Rheum Dis, vol. 77, pp. 1750-1756, 2018.
, “Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study”, Arthritis Res Ther, vol. 20, p. 243, 2018.
, “Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study”, BMC Med, vol. 16, p. 4, 2018.
, “Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy”, Cmaj, vol. 190, pp. E581-e587, 2018.
, “Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study”, Osteoporos Int, vol. 29, pp. 1659-1664, 2018.
, “The risk of gout among patients with sleep apnea: a matched cohort study”, Arthritis Rheumatol, 2018.
, , “Gout and subsequent erectile dysfunction: a population-based cohort study from England”, Arthritis Res Ther, vol. 19, p. 123, 2017.
, “Incident acute pseudogout and prior bisphosphonate use: Matched case-control study in the UK-Clinical Practice Research Datalink”, Medicine (Baltimore), vol. 96, p. e6177, 2017.
, “An algorithm to identify rheumatoid arthritis in primary care: a Clinical Practice Research Datalink study”, BMJ Open, vol. 5, p. e009309, 2015.
, “Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database”, Ann Rheum Dis, vol. 73, pp. 1769-73, 2014.
, “Risk of vascular events in patients with polymyalgia rheumatica”, Cmaj, vol. 186, pp. E495-501, 2014.
,